Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) is now available.
Clarity Pharmaceuticals Ltd. has announced that Citigroup Global Markets Australia Pty Limited and its related bodies corporate have ceased to be substantial holders of Clarity Pharmaceuticals as of September 19, 2025. This change in substantial holding reflects a decrease in relevant interest by Citibank, N.A. Sydney Branch, Citigroup Global Markets Australia Pty Limited, and Citigroup Global Markets Limited, impacting the company’s shareholder structure and potentially influencing market perceptions and investor relations.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,301,059
Technical Sentiment Signal: Buy
Current Market Cap: A$1.39B
For a thorough assessment of CU6 stock, go to TipRanks’ Stock Analysis page.